HONG KONG, Feb. 25, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab, Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a clinical trial collaboration with Pfizer Inc. (NYSE: PFE) to evaluate ivonescimab, a novel, investigational PD-1 / VEGF bispecific antibody, in...
GOTHENBURG, Sweden, Jan. 22, 2025 /PRNewswire/ -- SKF's Nomination Committee proposes Mats Rahmström as a new board member in AB SKF.
Mats Rahmström was the...
LONDON, Jan. 22, 2025 /PRNewswire/ -- UBTECH (HK 9880), a global leader in AI education, showcased a comprehensive range of integrated solutions for K-12, vocational...